Clinical Trial Update: A Study to Evaluate Safety and Immune Response of Novartis Meningococcal ACWY Conjugate Vaccine In US Adolescents and Adults [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating the safety and immune response of the Novartis Meningococcal ACWY conjugate vaccine (Menveo) in US adolescents and adults; the study ha…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Meningococcal Infections
• Meningococcal Meningitis

Drugs mentioned

• Menveo (meningococcal group A, C, W-135 and Y conjugate vaccine)

Snippet

Sponsor: Novartis Vaccines | Conditions: Meningococcal Infections, Meningococcal Meningitis | Phase 3 | Status: COMPLETED | Results posted: 2010-09-24